Literature DB >> 8617888

Potentiation of the immune response in HIV-1+ individuals.

T Schmitz1, R Underwood, R Khiroya, W W Bachovchin, B T Huber.   

Abstract

T cells from HIV-1+ individuals have a defect in mounting an antigen specific response. HIV-1 Tat has been implicated as the causative agent of this immunosuppression. We have previously shown that HIV-1 Tat inhibits antigen specific proliferation of normal T cells in vitro by binding to the accessory molecule CD26, a dipeptidase expressed on the surface of activated T cells. We now demonstrate that the defective in vitro recall antigen response in HIV-1 infected individuals can be restored by the addition of soluble CD26, probably by serving as a decoy receptor for HIV-1 Tat. The restored response is comparable to that of an HIV-1- individual, suggesting that early in HIV infection there is a block in the memory cell response, rather than deletion of these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617888      PMCID: PMC507215          DOI: 10.1172/JCI118577

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane. Purification by immunoadsorbent chromatography and some properties.

Authors:  B Svensson; M Danielsen; M Staun; L Jeppesen; O Norén; H Sjöström
Journal:  Eur J Biochem       Date:  1978-10-16

2.  Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Authors:  W G Gutheil; M Subramanyam; G R Flentke; D G Sanford; E Munoz; B T Huber; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  [Kinetics of dipeptidyl-peptidase IV].

Authors:  B Wolf; G Fischer; A Barth
Journal:  Acta Biol Med Ger       Date:  1978

4.  Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.

Authors:  Y Yang; J Bailey; M S Vacchio; R Yarchoan; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development.

Authors:  Y Yang; M S Vacchio; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

Authors:  C J Li; D J Friedman; C Wang; V Metelev; A B Pardee
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

Review 7.  Cytochemistry of membrane proteases.

Authors:  R Gossrau
Journal:  Histochem J       Date:  1985-07

8.  Human immunodeficiency virus Tat induces functional unresponsiveness in T cells.

Authors:  N Chirmule; S Than; S A Khan; S Pahwa
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

Authors:  M O Westendorp; R Frank; C Ochsenbauer; K Stricker; J Dhein; H Walczak; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

10.  Isolation and characterization of dipeptidyl peptidase IV from human placenta.

Authors:  G Püschel; R Mentlein; E Heymann
Journal:  Eur J Biochem       Date:  1982-08
View more
  6 in total

1.  Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.

Authors:  S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; E Vaccher; G Nasti; D Politi; L Barzan; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.

Authors:  N M Keane; P Price; S Lee; S F Stone; M A French
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

4.  Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.

Authors:  Virginia Boccardi; Luigi Marano; Rosaria Rita Amalia Rossetti; Maria Rosaria Rizzo; Natale di Martino; Giuseppe Paolisso
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

Review 5.  Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.

Authors:  Aurelio Cafaro; Antonella Tripiciano; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Stefano Buttò; Paolo Monini; Barbara Ensoli
Journal:  Vaccines (Basel)       Date:  2019-08-26

Review 6.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.